María Ferré Vallverdú

Sacubitril-Valsartan in a Routine Community Population: Attention to Volume Status Critical to Achieving Target Dose

Rebabonye B. Pharithi, María Ferré Vallverdú, Alan S. Maisel et al. · ESC Heart Failure · 2020 · 32 citations · Full text

Medicine, Cardiology, Pharmacology +16

Comparison of 1-Year Outcome in Patients With Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)

Hugo González‐Saldívar, Carlos Pascual, Gonzalo de la Morena et al. · The American Journal of Cardiology · 2016 · 28 citations · Full text

Medicine, Cardiology, Surgery +13

Neutrophil extracellular traps (NETs) in patients with STEMI. Association with percutaneous coronary intervention and antithrombotic treatments

María Ferré Vallverdú, Ana María Latorre, María Paz Fuset et al. · Thrombosis Research · 2022 · 22 citations

Medicine, Cardiology, Immunology +16

Prognostic value and clinical predictors of intramyocardial hemorrhage measured by CMR T2* sequences in STEMI

María Ferré Vallverdú, Elena Sánchez-Lacuesta, Diego Plaza-López et al. · International journal of cardiac imaging · 2021 · 14 citations

Medicine, Cardiology, Clinical Cardiology +12

Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm

María Ferré Vallverdú, Carmen Ligero, Rafael Vidal-Pérez et al. · Clinical Interventions in Aging · 2021 · 10 citations · Full text

Medicine, Cardiology, Internal Medicine +13